DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Retamar P, López-Cerero L, Muniain MA, Pascual Á, Rodríguez-Baño J ; ESBL-REIPI/GEIH Group.
Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.
Antimicrob Agents Chemother 2013;
57 (7) 3402-3404
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.